Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Katherine Tzou

Concepts (107)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
7
2019
972
0.900
Why?
Radiosurgery
3
2019
398
0.580
Why?
Prostate-Specific Antigen
4
2022
162
0.570
Why?
Databases, Factual
2
2019
1493
0.420
Why?
Neoplasm Recurrence, Local
4
2017
1160
0.420
Why?
Radium
2
2022
4
0.310
Why?
Salvage Therapy
6
2017
166
0.300
Why?
Prostatic Neoplasms, Castration-Resistant
2
2022
54
0.290
Why?
Bone Neoplasms
2
2022
272
0.250
Why?
Melanoma
2
2022
765
0.180
Why?
Radiation Injuries
2
2013
149
0.180
Why?
Prostatectomy
4
2017
93
0.170
Why?
Meta-Analysis as Topic
1
2022
173
0.160
Why?
Aged, 80 and over
8
2019
8391
0.140
Why?
Neuroma, Acoustic
1
2019
50
0.140
Why?
Testicular Neoplasms
1
2019
108
0.140
Why?
Prognosis
4
2019
4351
0.130
Why?
Dura Mater
1
2017
41
0.130
Why?
GATA2 Transcription Factor
1
2017
14
0.130
Why?
Kallikreins
1
2016
25
0.120
Why?
Meningeal Neoplasms
1
2017
95
0.120
Why?
Hepatocyte Nuclear Factor 3-alpha
1
2016
9
0.120
Why?
Drug Resistance, Neoplasm
1
2022
893
0.120
Why?
MicroRNAs
1
2022
699
0.110
Why?
Data Collection
1
2018
650
0.110
Why?
Prostate
1
2016
159
0.110
Why?
Biomarkers, Tumor
1
2022
1339
0.100
Why?
Glioblastoma
1
2017
350
0.100
Why?
Rectal Diseases
1
2013
24
0.100
Why?
Patient Reported Outcome Measures
1
2018
516
0.100
Why?
Radiotherapy, Conformal
1
2013
75
0.100
Why?
Aged
9
2019
26432
0.090
Why?
Combined Modality Therapy
4
2019
1271
0.090
Why?
Male
15
2022
73396
0.090
Why?
Brachytherapy
1
2013
132
0.090
Why?
Follow-Up Studies
2
2019
5439
0.090
Why?
Middle Aged
10
2019
36619
0.090
Why?
Chemotherapy, Adjuvant
2
2017
429
0.090
Why?
Practice Guidelines as Topic
1
2019
1591
0.090
Why?
Retrospective Studies
6
2022
17438
0.080
Why?
Neoplasm Metastasis
3
2019
693
0.080
Why?
Embolization, Therapeutic
1
2013
246
0.080
Why?
Practice Patterns, Physicians'
1
2019
1408
0.080
Why?
Treatment Failure
1
2011
361
0.080
Why?
Skin Neoplasms
1
2016
806
0.070
Why?
Humans
17
2022
146342
0.070
Why?
Neoplasm Staging
3
2017
1488
0.060
Why?
Liver Neoplasms
1
2013
776
0.060
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2016
1998
0.060
Why?
Radiotherapy, Adjuvant
1
2007
222
0.060
Why?
Adult
6
2019
41087
0.060
Why?
Radiotherapy Dosage
2
2017
289
0.050
Why?
Medulloblastoma
1
2007
208
0.050
Why?
Interleukin-15
1
2004
96
0.050
Why?
Neoplasms, Experimental
1
2004
163
0.050
Why?
Interleukin-2
1
2004
434
0.050
Why?
Survival Analysis
2
2017
1378
0.050
Why?
Treatment Outcome
4
2022
11821
0.050
Why?
Immunotherapy, Adoptive
1
2004
356
0.040
Why?
Watchful Waiting
1
2019
90
0.030
Why?
Lomustine
1
2017
18
0.030
Why?
Risk Factors
3
2017
10921
0.030
Why?
Brain Neoplasms
1
2007
1325
0.030
Why?
Neurosurgical Procedures
1
2019
209
0.030
Why?
Craniotomy
1
2017
83
0.030
Why?
Immunoenzyme Techniques
1
2017
197
0.030
Why?
Fatal Outcome
1
2017
302
0.030
Why?
Aminoquinolines
1
2016
18
0.030
Why?
Ipilimumab
1
2016
44
0.030
Why?
Administration, Topical
1
2016
154
0.030
Why?
T-Lymphocytes
1
2004
2012
0.030
Why?
Coloring Agents
1
2016
88
0.030
Why?
Multivariate Analysis
1
2019
1543
0.030
Why?
Risk Assessment
2
2015
3712
0.030
Why?
Kaplan-Meier Estimate
1
2016
970
0.030
Why?
Contrast Media
1
2017
493
0.030
Why?
Organs at Risk
1
2013
37
0.020
Why?
Organ Sparing Treatments
1
2013
37
0.020
Why?
Dose-Response Relationship, Radiation
1
2013
141
0.020
Why?
Proportional Hazards Models
1
2017
1331
0.020
Why?
Yttrium Radioisotopes
1
2013
64
0.020
Why?
Radiation Protection
1
2013
41
0.020
Why?
Microspheres
1
2013
142
0.020
Why?
Radiography
1
2013
861
0.020
Why?
United States
2
2019
16136
0.020
Why?
Young Adult
2
2019
14330
0.020
Why?
Prospective Studies
1
2022
8123
0.020
Why?
Sensitivity and Specificity
1
2013
1998
0.020
Why?
Survival Rate
1
2013
2092
0.020
Why?
Female
5
2019
79499
0.020
Why?
Time Factors
1
2018
7109
0.020
Why?
Tomography, X-Ray Computed
1
2017
2786
0.020
Why?
Incidence
1
2013
2936
0.010
Why?
Antineoplastic Agents
1
2017
2219
0.010
Why?
Reproducibility of Results
1
2013
3416
0.010
Why?
Magnetic Resonance Imaging
1
2017
3926
0.010
Why?
Proto-Oncogene Proteins c-bcl-2
1
2004
237
0.010
Why?
Immunologic Memory
1
2004
369
0.010
Why?
Mice, Inbred BALB C
1
2004
1244
0.010
Why?
Clinical Trials as Topic
1
2007
1064
0.010
Why?
Lymphocyte Activation
1
2004
1137
0.010
Why?
Adolescent
1
2019
22557
0.010
Why?
Infant, Newborn
1
2007
6460
0.010
Why?
Infant
1
2007
10114
0.010
Why?
Child, Preschool
1
2007
11913
0.010
Why?
Mice
1
2004
18297
0.000
Why?
Animals
1
2004
38106
0.000
Why?
Tzou's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)